We are live on ! Find out more
KA

Kinnevik AB Portfolio holdings

AUM $65.6M
1-Year Est. Return 25.95%
This Fund
S&P 500
This Quarter Est. Return
-16.99%
1 Year Est. Return
-25.95%
3 Year Est. Return
-51.41%
5 Year Est. Return
10 Year Est. Return
AUM
$74.5M
AUM Growth
-$103M
Cap. Flow
-$87.1M
Cap. Flow %
-116.86%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$87.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.58B
$51M 68.47%
7,653,061
BBLN
2
DELISTED
Babylon Holdings Limited
BBLN
$23.5M 31.53%
4,617,340
TDOC icon
3
Teladoc Health
TDOC
$1.66B
-3,683,668
Closed -$87.1M

Similar funds

Kinnevik AB's Q1 2023 Portfolio in Review

As of Q1 2023, Kinnevik AB held 3 positions worth $74.5M, down 58% from $177M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Kinnevik AB withdrew a net $87.1M in Q1 2023, closing 1 position. Its most notable exit was Teladoc Health, an estimated $87.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Kinnevik AB fully exited Teladoc Health in Q1 2023, selling an estimated $87.1M.
  • Kinnevik AB's ten largest holdings make up 100% of its $74.5M portfolio in Q1 2023.
  • Kinnevik AB opened 0 new positions and closed 1 in Q1 2023.
  • Kinnevik AB's portfolio value fell 58% quarter-over-quarter to $74.5M.

Based on Kinnevik AB's 13F filing for Q1 2023, filed 14 Apr 2023.